A Single Dose Study to Evaluate the Pharmacokinetics of Acoramidis Modified Release Formulations in Healthy Subjects
Clinical trial NCT04769479 · COMPLETED
Trial details
- NCT number
- NCT04769479
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-28
- Primary completion
- 2021-08-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.